TitleInterleukin-6 as a predictor of symptom resolution in psychological distress: a cohort study.
Publication TypeJournal Article
Year of Publication2015
AuthorsVirtanen, M, Shipley, MJ, Batty, GD, Hamer, M, Allan, CL, Lowe, GD, Ebmeier, KP, Akbaraly, TN, Alenius, H, Haapakoski, R, Singh-Manoux, A, Kivimäki, M
JournalPsychol Med
Volume45
Issue10
Pagination2137-44
Date Published07/2015
ISSN1469-8978
KeywordsAdult, Aged, Chronic Disease, Cohort Studies, Enzyme-Linked Immunosorbent Assay, Female, Health Status Indicators, Humans, Interleukin-6, Male, Middle Aged, Remission Induction, Stress, Psychological, United Kingdom
Abstract
 

BACKGROUND: Elevated levels of interleukin-6 (IL-6) have been associated with the development of common mental disorders, such as depression, but its role in symptom resolution is unclear.

METHOD: We examined the association between IL-6 and symptom resolution in a non-clinical sample of participants with psychological distress.

RESULTS: Relative to high IL-6 levels, low levels at baseline were associated with symptom resolution at follow-up [age- and sex-adjusted risk ratio (RR) = 1.15, 95% confidence interval (CI) 1.06-1.25]. Further adjustment for covariates had little effect on the association. Symptomatic participants with repeated low IL-6 were more likely to be symptom-free at follow-up compared with those with repeated high IL-6 (RR = 1.21, 95% CI 1.03-1.41). Among the symptomatic participants with elevated IL-6 at baseline, IL-6 decreased along with symptom resolution.

CONCLUSIONS: IL-6 is potentially related to the mechanisms underlying recovery from symptoms of mental ill health. Further studies are needed to examine these mechanisms and to confirm the findings in relation to clinical depression.

DOI10.1017/S0033291715000070
Alternate JournalPsychol Med
PubMed ID25697833
Grant List / / British Heart Foundation / United Kingdom
RG/13/2/30098 / / British Heart Foundation / United Kingdom
G1001354 / / Medical Research Council / United Kingdom
K013351 / / Medical Research Council / United Kingdom
MR/K013351/1 / / Medical Research Council / United Kingdom
R01AG034454 / AG / NIA NIH HHS / United States
R01HL036310 / HL / NHLBI NIH HHS / United States
R01AG013196 / AG / NIA NIH HHS / United States